-
Haɗa JYMed Peptide a Pharmaconex 2025
JYMed Peptide yana farin cikin gayyatar ku zuwa Pharmaconex 2025, wanda zai gudana daga Satumba 1-3, 2025, a Cibiyar Baje kolin Masarautar Masar (EIEC) a Alkahira. Rufe filin nuni na murabba'in murabba'in 12,000+, taron zai karbi bakuncin masu baje kolin 350+ kuma ana sa ran zai jawo hankalin masu sana'a 8,000+ ...Kara karantawa -
Haɗa JYMed Peptide a CPhI Korea 2025
JYMed Peptide yana farin cikin gayyatar ku zuwa CPhI Korea 2025, wanda zai gudana daga Agusta 26-28, 2025, a Cibiyar Taron COEX & Nunin a Seoul. Tsawon murabba'in murabba'in mita 15,000, ana sa ran taron zai karbi bakuncin masu baje koli fiye da 450 kuma yana maraba da maziyartan kwararru sama da 10,000. A shekarar 2024...Kara karantawa -
Shiga JYMed a CPHI Kudu maso Gabashin Asiya 2025
Muna farin cikin shiga cikin shugabannin masana'antu a CPHI Kudu maso Gabashin Asiya 2025, wanda ke faruwa daga Yuli 16 zuwa 18 a MITEC a Kuala Lumpur. Taron ya zagaya sama da murabba'in murabba'in 15,000 kuma zai ƙunshi masu nunin 400. Fiye da kwararru 8,000 ne ake sa ran za su halarta, tare da tarukan karawa juna sani na 60+ da tarukan f...Kara karantawa -
CPHI ShangHai 2025
Daga ranar 24 zuwa 26 ga watan Yunin shekarar 2025, an yi nasarar gudanar da bikin baje koli na kasa da kasa karo na 23 na kasar Sin CPhI a babban dakin baje koli na birnin Shanghai! Kungiyar ta tsunduma kai tsaye tare da cikakken l...Kara karantawa -
Haɗu da JYMed a Makon Interphex Tokyo 2025
Muna farin cikin sanar da cewa JYMed za ta baje kolin a makon Interphex Tokyo daga Yuli 9 zuwa 11, 2025, a Tokyo Big Sight (Ariake). Wannan babban taron ya haɗa kan masu baje kolin 90 da kusan ƙwararrun 34,000 daga ko'ina cikin masana'antar harhada magunguna da kayan shafawa. Kamar yadda daya daga cikin Asiya ...Kara karantawa -
Shiga JYMed a CPHI China 2025
CPHI China 2025 zai gudana daga Yuni 24-26, 2025, a Shanghai New International Expo Center (SNIEC). Fiye da murabba'in murabba'in mita 230,000, an saita taron don ɗaukar nauyin masu baje kolin 3,500 kuma ya jawo hankalin ƙwararrun masana'antu sama da 100,000. A matsayin daya daga cikin mafi girma a Asiya kuma mafi tasiri ...Kara karantawa -
JYMED'S PEPTIDE PRESSION BASE A HUBEI YA WUCE HUKUNCIN FADA NA BIYU.
Hubei JXBio Pharmaceutical Co., Ltd., JYMed ta sadaukar da peptide samar da wurin samar, samu nasarar kammala wani a kan-site dubawa da US Food and Drug Administration (FDA) daga Maris 10-14. Binciken, wani ɓangare na Binciken Tabbatar da Ingancin Magunguna, an kimanta mahimman tsarin da suka haɗa da inganci, samfura...Kara karantawa -
JYMED PEPTIDE YA KARBI KWALLON KAFA UKU
JYMed ya aiwatar da ingantaccen tsarin gudanarwa mai inganci, yana samun takaddun shaida guda uku don isar da samfuran akai-akai da sabis waɗanda suka dace da ka'idodin duniya. Nasarar takaddun shaida na ISO 9001 ya nuna cewa kamfanin yana da ingantattun matakai da ka'idoji don gudanar da cikin gida ...Kara karantawa -
HADU DA JYMED A ABUBUWA 3 NA DUNIYA A 2025
Muna farin cikin shiga ExpoFarma (Mexico City), IPhEB (St. Petersburg), da In-Cosmetics Global (Amsterdam) a cikin 2025. Ku zo ku haɗa tare da ƙungiyarmu kuma bincika damar haɗin gwiwa. Expo Farma 2025 Ranaku: Afrilu 2–4, 2025 Wuri: Cibiyar Ciniki ta Duniya, Birnin Mexico Wanda Asociación ya shirya...Kara karantawa -
ANA BAYAR DA BANGAREN BANGAREN TUURA GA RUWAN LIRAGLUTIDE
An bai wa JYMed lambar yabo ta Turai don sabbin hanyoyin kirkirar ta na Liraglutide. Wannan ci gaban yana nuna ci gaba da jagoranci a cikin peptide R&D da IP. Wannan lamban kira yana wakiltar sabon tsari don haɗa liraglutide, wanda ba wai kawai yana tabbatar da ingantaccen amfanin ƙasa ba har ma da mahimmanci ...Kara karantawa -
Labarai masu kayatarwa | JYMed Ya Amince da Fayilolin DMF don Sabbin Kayayyaki Biyar a Amurka
Kwanan nan, Shenzhen JYMed Technology Co., Ltd. (wanda ake kira "JYMed") ya sami nasarar kammala fayilolin Drug Master File (DMF) don ƙarin samfura guda biyar tare da Hukumar Abinci da Magunguna ta Amurka (FDA), ta ƙara faɗaɗa fayil ɗin samfurin ta. GAME JYMED JYMed shine...Kara karantawa -
JYMED yana gayyatar ku zuwa PCHi 2025 a Guangzhou
JYMED da gaske tana gayyatar ku da ku kasance tare da mu a 2025 PCHi Cosmetic Ingredients Exhibition a Guangzhou don bincika sabbin hanyoyin kasuwa, sabbin fasahohi, da dokokin ƙasa da ƙasa. Ziyarce mu a Booth 6J07! Guan 2025...Kara karantawa -
Labarai masu kayatarwa | Kayan Aikin Samar da Peptide na JYMed yana karɓar Takaddun shaida na WC
Kwanan nan, JYMed ta peptide samar da makaman, Hubei Jianxiang Biopharmaceutical Co., Ltd., samu biyu hukuma takardun bayar da Hubei lardin Drug Administration bayar: da "Drug GMP Compliance Inspection Result Notification" (No. E GMP 2024-258 da No. E4-2602)Kara karantawa -
Labarai masu kayatarwa | Mafi Girman Kayan Samar da Semaglutide API na China Ya Wuce Binciken FDA na Amurka
Daga 26 ga Agusta zuwa 30 ga Agusta, 2024, wurin samar da peptide na JYMed, Hubei JX Bio-Pharmaceutical Co., Ltd., ya yi nasarar shawo kan wani binciken da Hukumar Abinci da Magunguna ta Amurka (FDA) ta gudanar. Binciken ya kunshi muhimman wurare...Kara karantawa -
2024 CPHI Milan Pharmaceutical Nunin Recap
01. Baje kolin Baje kolin A ranar 8 ga Oktoba, 2024 CPHI Worldwide Pharmaceutical Exhibition ya fara a Milan. A matsayin daya daga cikin muhimman abubuwan da suka faru na shekara-shekara a masana'antar harhada magunguna ta duniya, ya jawo mahalarta daga kasashe da yankuna 166. Da over...Kara karantawa -
Labarai masu kayatarwa | JYMed's Liraglutide API yana karɓar Takaddun shaida na WC
A ranar 12 ga Oktoba, 2024, JYMed's Liraglutide API ya sami takaddun Tabbacin Rubuce-rubuce (WC), wanda ke nuna muhimmin mataki ga nasarar fitar da API zuwa kasuwar EU. WC (Tabbacin Rubuce-rubuce)...Kara karantawa -
Labari Mai Dadi: JYMed's Leuprorelin Acetate Ya Wuce Binciken Rijistar Magunguna
Kwanan nan, JYMed Technology Co., Ltd. ya sanar da cewa Leuprorelin Acetate, wanda reshensa na Hubei JX Bio-Pharmaceutical Co., Ltd. ya samar, ya yi nasarar wuce binciken rajistar magunguna. Kasuwar Magani ta asali...Kara karantawa -
Taya murna JYMed's Tirzepatide Ya Kammala Shigar US-DMF
JYMed Technology Co., Ltd. ya yi farin cikin sanar da cewa samfurinsa, Tirzepatide, ya yi nasarar kammala rajistar Drug Master File (DMF) tare da US FDA (Lambar DMF: 040115) kuma ya karbi Amincewar FDA ...Kara karantawa -
JYMed ya halarci PCT 2024 a Shanghai
PCT2024 Babban Taron Fasaha na Kula da Lafiya & Nunin wani lamari ne mai matukar tasiri a yankin Asiya-Pacific, yana mai da hankali kan musayar fasaha da nune-nune a cikin masana'antar samfuran kulawa ta sirri.Taron zai rufe fannoni daban-daban na masana'antar kulawa ta sirri, gami da fasaha a cikin ...Kara karantawa -
JYMed Peptide yana gayyatar ku don halartar Nunin Kayan Kayan Kayan Kaya na Koriya ta 2024
Wuri: Cibiyar Baje kolin Koriya ta Duniya Kwanan wata: Yuli 24-26, 2024 Time: 10:00 AM - 5:00 PM Adireshi: Cibiyar Nunin COEX Hall C, 513 Yeongdong-daero, Gangnam-gu, Seoul, 06164 In-cosmetics shine babban rukunin baje kolin kasa da kasa a cikin…Kara karantawa
